Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery Disease

Tairo Kurita(Mie University), Shinjo Sonoda(University of Occupational and Environmental Health Japan), Takenori Domei(Kokura Memorial Hospital), Nobuhiro Suematsu(Saiseikai Fukuoka General Hospital), Tatsuya Saigusa(Shinshu University), Yuetsu Kikuta(Imperial College London), Kenichi Tsujita(Kumamoto University), Fumitoshi Toyota(Fukuoka Hospital), Kaoru Dohi(Mie University), Tatsuki Doijiri(Seiwa Hospital), Hidenobu Terai(Kanazawa Hospital), Jun Shiraishi(Osaka International Cancer Institute), Akihiro Takasaki(Mie University), Shoichi Kuramitsu(Kokura Memorial Hospital), Nobuhiro Tanaka(Tokyo Medical University Hachioji Medical Center), Tomohiro Sakamoto(Saiseikai Kumamoto Hospital), Taku Asano(Amsterdam UMC Location University of Amsterdam), Hiroyuki Isogai(Aichi Medical University), Ken Harada(Ibaraki University), Takayuki Ishihara(Kansai Rosai Hospital), Manabu Ogita(Juntendo University Shizuoka Hospital), Yasutsugu Shiono(Imperial College London), Kazunori Horie(Sendai Kousei Hospital), Hitoshi Matsuo, Hirohiko Ando(Aichi Medical University), Hiroyoshi Yokoi(Kurume University), Reo Anai(University of Occupational and Environmental Health Japan), Masanobu Ishii(Kumamoto Health Science University), Katsuhiko Masamura(Nakamura Memorial Hospital)
Circulation Reports
July 19, 2024
10.1253/circrep.cr-24-0069
Cited by 2

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|410